Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220786629> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W4220786629 endingPage "282" @default.
- W4220786629 startingPage "277" @default.
- W4220786629 abstract "Propranolol is used as the first-line treatment for infantile hemangiomas (IHs). As oral formulations can cause systemic adverse drug reactions (ADRs), we prepared topical propranolol formulations and evaluated their pharmaceutical profiles. We also present three cases of pediatric patients with IHs who were treated with the propranolol formulations. Propranolol cream (hydrophilic cream, 1, 3, and 5%) and gels (carboxyvinyl polymer, hydroxypropyl methylcellulose, gellan gum, 1%) were prepared. The in vitro skin permeability of these formulations was assessed using Franz-type diffusion cells. The pharmaceutical profiles, including propranolol content, pH, and ductility, of the propranolol creams were evaluated. For the stability test, similar pharmaceutical evaluations were performed after the creams were stored at 25 °C and 56% relative humidity for 3 months. We examined three patients treated with propranolol cream to investigate the clinical course of IH and adverse events after the propranolol cream was applied for 5–12 months. In the in vitro skin permeability assay, topical propranolol formulations made of hydrophilic cream and gellan gum permeated the most. The amount of propranolol that permeated increased with propranolol concentration. After storage for 3 months, no substantial changes were observed in any pharmaceutical profile. The IHs were discolored in all patients. Tumor size also decreased in some patients. Furthermore, no adverse events caused by propranolol cream were observed during application. In conclusion, propranolol cream can be prepared as a hospital formulation with adequate quality. Topical propranolol therapy is effective in reducing the incidence of systemic ADRs." @default.
- W4220786629 created "2022-04-03" @default.
- W4220786629 creator A5005542616 @default.
- W4220786629 creator A5013676622 @default.
- W4220786629 creator A5019962400 @default.
- W4220786629 creator A5021795928 @default.
- W4220786629 creator A5025239713 @default.
- W4220786629 creator A5035516332 @default.
- W4220786629 creator A5064497396 @default.
- W4220786629 creator A5071346122 @default.
- W4220786629 creator A5072672539 @default.
- W4220786629 date "2022-04-01" @default.
- W4220786629 modified "2023-10-14" @default.
- W4220786629 title "Topical Formulations of Propranolol for Infantile Hemangiomas: Characteristics of Formulations and Three Cases of Infants Administered Topical Propranolol Cream" @default.
- W4220786629 cites W1625659952 @default.
- W4220786629 cites W1907271927 @default.
- W4220786629 cites W198184909 @default.
- W4220786629 cites W1987326721 @default.
- W4220786629 cites W1996304541 @default.
- W4220786629 cites W2002640235 @default.
- W4220786629 cites W2022254251 @default.
- W4220786629 cites W2028409600 @default.
- W4220786629 cites W2048807856 @default.
- W4220786629 cites W2060268028 @default.
- W4220786629 cites W2067540888 @default.
- W4220786629 cites W2084308109 @default.
- W4220786629 cites W2116932780 @default.
- W4220786629 cites W2169876742 @default.
- W4220786629 cites W2328338930 @default.
- W4220786629 cites W2507673555 @default.
- W4220786629 cites W2525918371 @default.
- W4220786629 cites W2790100424 @default.
- W4220786629 cites W2807276509 @default.
- W4220786629 cites W2906007348 @default.
- W4220786629 cites W2980480972 @default.
- W4220786629 cites W4206073004 @default.
- W4220786629 doi "https://doi.org/10.1248/cpb.c21-00997" @default.
- W4220786629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35370204" @default.
- W4220786629 hasPublicationYear "2022" @default.
- W4220786629 type Work @default.
- W4220786629 citedByCount "1" @default.
- W4220786629 countsByYear W42207866292022 @default.
- W4220786629 crossrefType "journal-article" @default.
- W4220786629 hasAuthorship W4220786629A5005542616 @default.
- W4220786629 hasAuthorship W4220786629A5013676622 @default.
- W4220786629 hasAuthorship W4220786629A5019962400 @default.
- W4220786629 hasAuthorship W4220786629A5021795928 @default.
- W4220786629 hasAuthorship W4220786629A5025239713 @default.
- W4220786629 hasAuthorship W4220786629A5035516332 @default.
- W4220786629 hasAuthorship W4220786629A5064497396 @default.
- W4220786629 hasAuthorship W4220786629A5071346122 @default.
- W4220786629 hasAuthorship W4220786629A5072672539 @default.
- W4220786629 hasBestOaLocation W42207866291 @default.
- W4220786629 hasConcept C185592680 @default.
- W4220786629 hasConcept C197934379 @default.
- W4220786629 hasConcept C2778151854 @default.
- W4220786629 hasConcept C2781220964 @default.
- W4220786629 hasConcept C2909915070 @default.
- W4220786629 hasConcept C31903555 @default.
- W4220786629 hasConcept C42219234 @default.
- W4220786629 hasConcept C43617362 @default.
- W4220786629 hasConcept C45904493 @default.
- W4220786629 hasConcept C71924100 @default.
- W4220786629 hasConcept C77281830 @default.
- W4220786629 hasConcept C98274493 @default.
- W4220786629 hasConceptScore W4220786629C185592680 @default.
- W4220786629 hasConceptScore W4220786629C197934379 @default.
- W4220786629 hasConceptScore W4220786629C2778151854 @default.
- W4220786629 hasConceptScore W4220786629C2781220964 @default.
- W4220786629 hasConceptScore W4220786629C2909915070 @default.
- W4220786629 hasConceptScore W4220786629C31903555 @default.
- W4220786629 hasConceptScore W4220786629C42219234 @default.
- W4220786629 hasConceptScore W4220786629C43617362 @default.
- W4220786629 hasConceptScore W4220786629C45904493 @default.
- W4220786629 hasConceptScore W4220786629C71924100 @default.
- W4220786629 hasConceptScore W4220786629C77281830 @default.
- W4220786629 hasConceptScore W4220786629C98274493 @default.
- W4220786629 hasIssue "4" @default.
- W4220786629 hasLocation W42207866291 @default.
- W4220786629 hasLocation W42207866292 @default.
- W4220786629 hasOpenAccess W4220786629 @default.
- W4220786629 hasPrimaryLocation W42207866291 @default.
- W4220786629 hasRelatedWork W2023696243 @default.
- W4220786629 hasRelatedWork W2049499810 @default.
- W4220786629 hasRelatedWork W2056115014 @default.
- W4220786629 hasRelatedWork W2189278723 @default.
- W4220786629 hasRelatedWork W2415082248 @default.
- W4220786629 hasRelatedWork W2899084033 @default.
- W4220786629 hasRelatedWork W2954294567 @default.
- W4220786629 hasRelatedWork W3118540046 @default.
- W4220786629 hasRelatedWork W4220786629 @default.
- W4220786629 hasRelatedWork W2132969918 @default.
- W4220786629 hasVolume "70" @default.
- W4220786629 isParatext "false" @default.
- W4220786629 isRetracted "false" @default.
- W4220786629 workType "article" @default.